secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-08-19T13:19:15+00:00
Accession:  0001213900-26-091438
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs annual meeting: directors elected, auditor ratified, charter amendment fails, adjourned to Sept 16
--------------------------------------------------------------------------------

- Six directors elected: Jonathan Cohen, John G. Compton, Richard M. Cohen, Prasanth Reddy, John W. Rollins, Michael A. Ross; each received >2.6M votes for.
- Ratified dbbmckennon as independent auditor for FY2026: 4,105,584 for, 132,421 against, 18,832 abstentions.
- Approved 2026 Equity Incentive Plan: 2,183,335 for, 573,931 against, 1,433,721 broker non-votes.
- Proposal 3 (Charter Amendment) failed to get sufficient votes; meeting adjourned to Sept 16, 2026 at 10:00 a.m. ET to solicit more proxies.
- Quorum: 4,256,837 shares represented out of 12,251,198 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026091438/0001213900-26-091438-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026091438/ea0302628-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-091438

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer